Wenyang Huang
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 27, 2026
Disease characteristics, treatment, and outcomes in Chinese chronic lymphocytic leukemia patients following BTK inhibitor discontinuation: a multicenter real-world study.
Journal: Frontiers in medicine
Published: November 04, 2025
Development and Validation of a Nomogram Model for Predicting Chorioamnionitis in Patients with Term Premature Rupture of Membranes.
Journal: International journal of women's health
Published: October 16, 2025
Total tumor apparent diffusion coefficient histogram analysis of whole-body DWI-MRI for prognostic stratification in patients with R-ISS stage II multiple myeloma.
Journal: Magnetic resonance imaging
Published: June 08, 2025
Long-term outcomes of CNCT19 chimeric antigen receptor T-cell therapy in relapsed or refractory aggressive B-cell lymphoma.
Journal: Chinese medical journal
Published: May 06, 2025
Long-term outcomes of CNCT19 chimeric antigen receptor T-cell therapy in relapsed or refractory aggressive B-cell lymphoma.
Journal: Chinese medical journal
Published: May 06, 2025
Identification of a CAR-Derived Clone by NGS-Based MRD After Fully Human BCMA CAR T-Cell Therapy in Multiple Myeloma.
Journal: American journal of hematology
Published: April 24, 2025
Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma.
Journal: The Journal of clinical investigation
Published: March 17, 2025
Continuous R-DA-EDOCH alternated with high-dose Ara-C induces deep remission and overcomes high-risk factors in young patients with newly diagnosed mantle cell lymphoma.
Journal: Cancer biology & medicine
Published: March 12, 2025
The optimal time and clinical implications of measurable residual disease detection in mantle cell lymphoma.
Journal: Annals of hematology
Published: October 28, 2024
Zanubrutinib plus Ixazomib and Dexamethasone in Newly Diagnosed Symptomatic Waldenström Macroglobulinemia: A Phase II Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 28, 2024
Dissecting the high-risk property of 1q gain/amplification in patients with newly diagnosed multiple myeloma.
Journal: American journal of cancer research
Published: September 12, 2024
Last Updated: 09/26/2026